These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10353633)

  • 21. Loss of the tumor suppressor p53 gene at the liver cirrhosis stage in Japanese patients with hepatocellular carcinoma.
    Kishimoto Y; Shiota G; Kamisaki Y; Wada K; Nakamoto K; Yamawaki M; Kotani M; Itoh T; Kawasaki H
    Oncology; 1997; 54(4):304-10. PubMed ID: 9216855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum.
    Chang YC; Ho CL; Chen HH; Chang TT; Lai WW; Dai YC; Lee WY; Chow NH
    Br J Cancer; 2002 Dec; 87(12):1449-53. PubMed ID: 12454776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma.
    Lauret E; Rodríguez M; González S; Linares A; López-Vázquez A; Martínez-Borra J; Rodrigo L; López-Larrea C
    Am J Gastroenterol; 2002 Apr; 97(4):1016-21. PubMed ID: 12003382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent concomitant epigenetic silencing of SOX1 and secreted frizzled-related proteins (SFRPs) in human hepatocellular carcinoma.
    Shih YL; Hsieh CB; Yan MD; Tsao CM; Hsieh TY; Liu CH; Lin YW
    J Gastroenterol Hepatol; 2013 Mar; 28(3):551-9. PubMed ID: 23215838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers.
    Liu X; Wang SK; Zhang K; Zhang H; Pan Q; Liu Z; Pan H; Xue L; Yen Y; Chu PG
    Carcinogenesis; 2015 Feb; 36(2):232-42. PubMed ID: 25542894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation of p53 gene in regenerative nodules in cirrhotic liver.
    Minouchi K; Kaneko S; Kobayashi K
    J Hepatol; 2002 Aug; 37(2):231-9. PubMed ID: 12127428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of DNA repair genes in active cirrhosis associated with hepatocellular carcinoma.
    Zindy P; Andrieux L; Bonnier D; Musso O; Langouët S; Campion JP; Turlin B; Clément B; Théret N
    FEBS Lett; 2005 Jan; 579(1):95-9. PubMed ID: 15620696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis.
    Nagasue N; Yukaya H; Ogawa Y; Kohno H; Nakamura T
    Ann Surg; 1987 Jul; 206(1):30-9. PubMed ID: 3038039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
    Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
    Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal expansion in evolution of chronic hepatitis to hepatocellular carcinoma as seen at an X-chromosome locus.
    Ochiai T; Urata Y; Yamano T; Yamagishi H; Ashihara T
    Hepatology; 2000 Mar; 31(3):615-21. PubMed ID: 10706551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis.
    Park YM; Choi JY; Byun BH; Cho CH; Kim HS; Kim BS
    Exp Mol Med; 1998 Mar; 30(1):35-40. PubMed ID: 9873820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different expression of VEGF and EGFL7 in human hepatocellular carcinoma.
    Campagnolo L; Telesca C; Massimiani M; Stuhlmann H; Angelico M; Lenci I; Manzia TM; Tariciotti L; Lehmann G; Baiocchi L
    Dig Liver Dis; 2016 Jan; 48(1):76-80. PubMed ID: 26542361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus-related hepatocellular carcinoma and liver cirrhosis.
    Pecic V; Stankovic-Djordjevic D; Nestorovic M; Radojkovic M; Marjanovic H; Ilic B; Milojkovic M
    J BUON; 2011; 16(2):277-81. PubMed ID: 21766498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
    Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
    Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial carcinoma and cirrhosis of liver: report of six members in two generations.
    Tansurat P
    J Med Assoc Thai; 1984 Sep; 67(9):529-34. PubMed ID: 6097626
    [No Abstract]   [Full Text] [Related]  

  • 37. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy.
    Terada T; Terasaki S; Nakanuma Y
    Cancer; 1993 Sep; 72(5):1551-6. PubMed ID: 8394196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic evaluation of the dysplasia-carcinoma sequence in chronic viral liver disease: a detailed analysis of two cases and a review of the literature.
    van Dekken H; Wink J; Alers JC; de Man RA; IJzermans JN; Zondervan PE
    Acta Histochem; 2003; 105(1):29-41. PubMed ID: 12666986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
    Chan KL; Guan XY; Ng IO
    Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.